NF-κb activation and inhibition:: A review

被引:213
作者
Sun, ZW [1 ]
Andersson, R [1 ]
机构
[1] Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden
来源
SHOCK | 2002年 / 18卷 / 02期
关键词
nuclear factor kappa beta; activation; inhibitor;
D O I
10.1097/00024382-200208000-00001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Among transcriptional regulatory proteins described, NF-kappaB seems particularly important in modulating the expression of immunoregulatory genes relevant in critical illness, inflammatory diseases, apoptosis, and cancer. In particular, NF-kappaB plays a central role in regulating the transcription of cytokines, adhesion molecules, and other mediators. The biochemical basis by which diverse stimuli converge to activate or intervene this family of transcription factors is still largely unknown. The NF-kappaB transcription factor family represents an important group of regulators of a broad range of genes involved in cellular responses to inflammatory and other kinds of signals. Knockout mouse studies have also revealed a key role for this family in broad physiological processes, including immune function and metabolism. Overall, specificity seems to exist in the role of each transcriptional complex in gene transcription and physiological function. Each NF-kappaB complex displays distinct affinities for the different DNA-binding sites present in the promoters of NF-kappaB-regulated genes, and this may contribute to some of the specificity exhibited. The identification of specific components of the NF-kappaB signal transduction pathway provides an opportunity to define mechanisms at the biochemical level by which specific members of the NF-kappaB family are activated. Furthermore, this may identify specific targets for selective inhibition or promotion of NF-kappaB functions. Further studies will be required to elucidate mechanisms regulating specificity and selectivity of NF-kappaB function, as well as its role in different diseases, prior to potential clinical application.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 64 条
[1]   NF-κB activation [J].
Abraham, E .
CRITICAL CARE MEDICINE, 2000, 28 (04) :N100-N104
[2]   NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: Inhibition by glucocorticoids does not require I-kappa B. [J].
Adcock, IM ;
Newton, R ;
Barnes, PJ .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) :S154-S154
[3]  
ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369
[4]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[6]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[7]   Nuclear factor kappa B [J].
Barnes, PJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) :867-870
[8]   Acute lung injury after hepatic cryoablation:: Correlation with NF-κB activation and cytokine production [J].
Blackwell, TS ;
Debelak, JP ;
Venkatakrishnan, A ;
Schot, DJ ;
Harley, DH ;
Pinson, CW ;
Williams, P ;
Washington, K ;
Christman, JW ;
Chapman, WC .
SURGERY, 1999, 126 (03) :518-526
[9]   Regulation of an essential innate immune response by the p50 subunit of NF-κB [J].
Bohuslav, J ;
Kravchenko, VV ;
Parry, GCN ;
Erlich, JH ;
Gerondakis, S ;
Mackman, N ;
Ulevitch, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) :1645-1652
[10]   Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators [J].
Bondeson, J ;
Foxwell, B ;
Brennan, F ;
Feldmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5668-5673